Cargando…

Evaluation of interleukins 37 and 38 and vitamin D status in the serum of women with Graves' disease

BACKGROUND: Graves' disease (GD) is an autoimmune thyroid disorder and recent studies have proposed a role for interleukin (IL)‐37, IL‐38, and vitamin D (VitD) in the pathophysiology of disease. Therefore, this study investigated the expression of IL‐37, IL‐38, and VitD in the serum of GD patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Hiba Y., Sulaiman, Ghassan M., Al‐shammaa, Mohamed S., Ad'hiah, Ali H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756989/ https://www.ncbi.nlm.nih.gov/pubmed/36397279 http://dx.doi.org/10.1002/jcla.24776

Ejemplares similares

Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
por: Ahmed, Aeshah A., et al.
Publicado: (2021)

Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients
por: Ahmed, Aeshah A., et al.
Publicado: (2022)

Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
por: Majeed, Abdulraheem Y., et al.
Publicado: (2023)

Interleukin-38 promoter variants and risk of COVID-19 among Iraqis
por: Al-Karaawi, Ibtihal A., et al.
Publicado: (2022)

Interleukin‐39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index
por: Nussrat, Shahad W., et al.
Publicado: (2023)

Soluble HLA-G is upregulated in serum of patients with severe COVID-19
por: Al-Bayatee, Noor T., et al.
Publicado: (2021)

Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
por: Majeed, Abdulraheem Y., et al.
Publicado: (2023)

Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)
por: Hamed, Roaa M., et al.
Publicado: (2023)

Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19
por: Al-Bayatee, Noor T., et al.
Publicado: (2021)

HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients
por: Ad'hiah, Ali H., et al.
Publicado: (2022)

Low serum interleukin‐38 levels in patients with Graves’ disease and Hashimoto’s thyroiditis
por: Xu, Jialu, et al.
Publicado: (2021)

Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients
por: Ad’hiah, Ali H., et al.
Publicado: (2021)

Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients
por: Mahmood, Zainab S., et al.
Publicado: (2022)

Evaluation of human β‑defensins in the cerebrospinal fluid of suspected meningitis
por: Jaleel, Lena K., et al.
Publicado: (2022)

Analysis of Serum Interleukin-37 Level and Prognosis in Patients with ACS
por: Liu, Canjun, et al.
Publicado: (2021)

Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease
por: Gong, Luping, et al.
Publicado: (2022)

Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients
por: Ad’hiah, Ali H., et al.
Publicado: (2020)

CERN Bulletin Issue No. 37-38/2017
Publicado: (2017)

CERN Bulletin Issue No. 37-38/2015
Publicado: (2015)

CERN Bulletin Issue No. 37-38/2014
Publicado: (2014)

CERN Bulletin Issue No. 37-38/2011
Publicado: (2011)

CERN Bulletin Issue No. 37-38/2009
Publicado: (2009)

CERN Bulletin Issue No. 37-38/2021
Publicado: (2021)

CERN Bulletin Issue No. 37-38/2017
Publicado: (2017)

CERN Bulletin Issue No. 37-38/2022
Publicado: (2022)

CERN Bulletin Issue No. 37-38/2022
Publicado: (2022)

Maternal serum iron status, hepcidin and interleukin-6 levels in women with preeclampsia
por: Ahmed, Yasir I. B., et al.
Publicado: (2023)

Serum vitamin D levels are decreased in patients without remission of Graves’ disease
por: Yasuda, Tetsuyuki, et al.
Publicado: (2012)

Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence
por: Zhang, Ying, et al.
Publicado: (2021)

The Role of IL-37 and IL-38 in Obstetrics Abnormalities
por: Wang, Mei
Publicado: (2021)

The Role of IL-37 and IL-38 in Colorectal Cancer
por: Dang, Jie, et al.
Publicado: (2022)

Vitamin D Status and Its Association with the SCORAD Score and Serum LL-37 Level in Korean Adults and Children with Atopic Dermatitis
por: Han, Tae Young, et al.
Publicado: (2015)

The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response
por: Elenius, Varpu, et al.
Publicado: (2017)

Changes in serum hepcidin according to thyrometabolic status in patients with Graves’ disease
por: Krygier, Aleksandra, et al.
Publicado: (2020)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Interleukin-37 as fundamental inhibitor of innate immunity
por: Bufler, P
Publicado: (2011)

The emerging role of interleukin‐37 in cardiovascular diseases
por: Zhuang, Xinyu, et al.
Publicado: (2017)

The Role of Interleukin-37 in the Pathogenesis of Allergic Diseases
por: Shilovskiy, I. P., et al.
Publicado: (2019)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

Interleukin-37 is involved in the immunopathogenesis of infectious mononucleosis
por: Zhao, Mingsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m53ljnfqphntl8uqtf2v04oe1p